The equine supplement products market size is projected to be USD 90.49 million in 2025, USD 91.88 million in 2026, and reach USD 104.42 million by 2031, growing at a CAGR of 2.59% from 2026 to 2031. This report is Segmented by Health Benefit / Application (Joint & Bone Health, and More), Ingredient Type (Proteins & Amino Acids, Vitamins, and More), Form (Powders, Liquids, and More), Distribution Channel (Veterinary Hospitals & Clinics, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Regulatory clarity in the United States supports this channel shift, since FDA’s final guidance on AAFCO-defined ingredients enables interstate commerce for listed feed ingredients, reducing uncertainty for compliant online sellers . Online approaches also allow rapid education on clean-label positioning and formulation science, which has become a determinant of conversion in higher value segments such as joint support and digestive health. As consumers diversify sourcing from physical retail to marketplaces and first-party sites, repeat purchase reliability and transparent ingredient disclosure are emerging as core differentiators.
A 12-week prospective study published in February 2026 reported that natural eggshell membrane supplementation improved rider-reported function and altered joint-angle kinematics in Warmblood horses with chronic lameness, which signals potential synergy from collagen, glycosaminoglycans, and hyaluronic acid components within a single matrix.
Cross-species findings in 2025 that combined curcumin C3 Complex with glucosamine and chondroitin to reduce osteoarthritis severity and inflammatory markers in canine models have influenced equine product development strategies for inflammatory modulation. Clean sport compliance remains a threshold requirement for elite use cases, and brands emphasize third-party quality systems and transparent labeling to navigate stringent competition rules in Europe and global federations. The combination of broader evidence, sport-specific nutrition demands, and regulatory diligence reinforces sustained demand for mobility-focused formulas.
These compliance considerations are magnified for companies that export across jurisdictions, since national implementations of feed hygiene and quality systems vary and can increase documentation and verification workloads. Competitive-sport requirements in Europe also drive manufacturers to invest in quality assurance schemes and supplier audits to mitigate contamination and meet clean-sport standards. Collectively, these regulatory and labeling complexities raise barriers for smaller entrants and contribute to uneven product consistency across markets.
Other drivers and restraints analyzed in the detailed report include:
Natural eggshell membrane has moved into the discussion after a February 2026 clinical study in Warmblood horses showed functional improvements over a 12-week schedule, which has helped expand formulator interest in collagen-rich complexes. Separate evidence in companion animals where curcumin C3 Complex combined with glucosamine and chondroitin reduced osteoarthritis severity has supported cross-species ingredient screening for equine joint health. Sports integrity is a parallel focus, and brands that operate in Europe emphasize quality systems and third-party testing frameworks to meet clean-sport expectations around competition eligibility. These trends are creating a more evidence-aware buyer who weighs ingredient provenance and trial endpoints when selecting joint formulas.
Hoof & Laminitis Support is the fastest-growing sub-application with a 4.51% CAGR forecast, and its momentum reflects closer coordination between farriers, veterinarians, and nutritionists targeting preventive lameness. Research into methylated tirilazad has reported reductions in laminar matrix metalloproteinase activity in experimental models, and although not yet approved for equine use, this work informs anti-inflammatory strategies that developers are tracking for future formulations. Biotin remains a staple of hoof support, and company guidance around sustained dosing supports owner compliance and farrier recommendations over extended time frames.
Digestive and gut health applications have expanded due to rising microbiome awareness, with attention to prebiotics that may support mucosal health in horses vulnerable to colic. As early evidence grows, application-level portfolios are tilting toward precision approaches rather than broad-spectrum blends, which can translate into clearer use cases at the point of care. These shifts reinforce the premium tier while also pushing formulators to document outcomes for owner-facing education and veterinary collaboration.
Proteins & Amino Acids led ingredient demand with a 41.24% share in 2025, supported by lysine, methionine, and threonine to aid topline development, hoof keratin quality, and reproductive function. The equine supplement products market continues to incorporate these building blocks in balanced rations, often anchored by essential amino acid combinations within broader feed and supplement regimens. Botanical and nutraceutical inputs are the fastest-growing at a 4.14% CAGR, supported in the United States by regulatory clarity that AAFCO-listed feed ingredients can move across state lines, which reduces uncertainty for compliant ingredient use in commercial products.
Clean-label strategies are gaining prominence, including the use of wild-harvested or minimally processed actives and transparent supply chains, as shown by company announcements that emphasize natural sourcing and formula simplicity. This momentum increases the need for validated dosing protocols and supporting data so owners and clinicians can line up ingredients with intended outcomes across metabolic and performance profiles. As ingredient portfolios broaden, product developers are also addressing carrier systems and stability to protect bioactive integrity through the digestive tract.
Vitamins present a mixed picture due to organic compliance challenges that stem from widespread use of genetically modified microorganisms in industrial production of certain B vitamins. The 2024 USDA National Organic Program report highlighted riboflavin and other vitamins as typically produced through GMO fermentation, which complicates organic claims for equine feeds and supplements without transparent disclosures or alternative sourcing.
Enzymes, probiotics, and synbiotics remain active areas for development, though studies in healthy horses show that not all commercial probiotic blends produce measurable immunological or microbiota shifts, encouraging more targeted strain selection and context-specific use. Electrolytes and minerals, including chelated forms of copper, zinc, and manganese, continue to be staples due to their roles in thermoregulation and musculoskeletal function in training and competition settings. With a growing body of microbiome and nutraceutical evidence, brands are adopting tighter documentation practices for both raw material credentials and finished-product testing. This combination of scientific discipline and quality control underpins the premiumization visible across leading ingredient segments.
Within the United States, labeling guidance for new animal drugs reinforces the need for clear label claims and careful separation between feed and drug positioning for any product that edges into therapeutic territory. With a large installed base of performance horses and a well-developed veterinary ecosystem, North America remains central to early adoption of innovation and to scaling clinically guided product lines. Overall, the region’s regulation, channel maturity, and customer education form a stable foundation for premiumization.
Europe displays steady growth under stricter pharmacovigilance and feed hygiene oversight, which encourages investments in quality systems and clean-sport validation. Brands that operate in the United Kingdom have retooled distribution relationships following post-Brexit trade changes, and a notable 2026 partnership for exclusive distribution has strengthened channel alignment for a leading sport-nutrition brand.
Asia-Pacific is projected to be the fastest-growing region with a 5.01% CAGR, a reflection of expanding equestrian participation and entrenched racing cultures that prioritize performance nutrition. Product development in Japan tends to emphasize microencapsulation and fermentation-derived inputs in line with local preferences for biotech-enabled nutrition, while Australia’s regulatory environment facilitates timely market access for compliant formulations. The equine supplement products market size in this region is influenced by a rising base of urban and peri-urban riders in select countries and by coaching ecosystems that encourage structured nutrition management across disciplines.
Global Equine Supplement Products Market Trends and Insights
Online Retail and D2C Penetration Reshapes Access and Assortment
The equine supplement products market continues to benefit from rapid e-commerce adoption, as online channels scale assortment beyond the constraints of local vet clinics and tack stores, with online retail identified as the fastest-growing distribution route in the forecast period. Direct-to-consumer programs that bundle diet analysis, subscription auto-ship, and curated formulations improve convenience and trust, exemplified by Mad Barn’s integrated content and service model that includes free ration analysis for horse owners. Digital tools such as ration calculators and telehealth tie-ins are becoming table stakes, helping brands reduce friction at the point of decision while reinforcing compliance with feeding protocols over time.Regulatory clarity in the United States supports this channel shift, since FDA’s final guidance on AAFCO-defined ingredients enables interstate commerce for listed feed ingredients, reducing uncertainty for compliant online sellers . Online approaches also allow rapid education on clean-label positioning and formulation science, which has become a determinant of conversion in higher value segments such as joint support and digestive health. As consumers diversify sourcing from physical retail to marketplaces and first-party sites, repeat purchase reliability and transparent ingredient disclosure are emerging as core differentiators.
Rising Joint and Bone Health Management in Performance and Aging Horses
Application-level demand in the equine supplement products market remains anchored by mobility and structural support, as owners seek to sustain performance and extend working lifespans in aging sport and leisure horses. Beyond legacy glucosamine-chondroitin and hyaluronic acid combinations, new multi-modal bioactives are entering clinician and trainer toolkits and are being validated with relevant functional endpoints in recent trials.A 12-week prospective study published in February 2026 reported that natural eggshell membrane supplementation improved rider-reported function and altered joint-angle kinematics in Warmblood horses with chronic lameness, which signals potential synergy from collagen, glycosaminoglycans, and hyaluronic acid components within a single matrix.
Cross-species findings in 2025 that combined curcumin C3 Complex with glucosamine and chondroitin to reduce osteoarthritis severity and inflammatory markers in canine models have influenced equine product development strategies for inflammatory modulation. Clean sport compliance remains a threshold requirement for elite use cases, and brands emphasize third-party quality systems and transparent labeling to navigate stringent competition rules in Europe and global federations. The combination of broader evidence, sport-specific nutrition demands, and regulatory diligence reinforces sustained demand for mobility-focused formulas.
Fragmented Regulation and Inconsistent Labeling/Quality Standards
Regulatory structures for animal supplements sit between feed and drug frameworks, which creates ambiguity in claims, labeling, and interstate commerce, particularly in the United States. FDA’s final guidance acknowledging AAFCO-defined feed ingredients provides a clearer path for compliant use of listed inputs in feeds, yet products that imply therapeutic intent can still be scrutinized under new animal drug rules. Labeling rules for approved or conditionally approved new animal drugs remain stringent, which makes botanical multi-constituent blends challenging to position if claims drift into treatment territory that would otherwise require drug pathways.These compliance considerations are magnified for companies that export across jurisdictions, since national implementations of feed hygiene and quality systems vary and can increase documentation and verification workloads. Competitive-sport requirements in Europe also drive manufacturers to invest in quality assurance schemes and supplier audits to mitigate contamination and meet clean-sport standards. Collectively, these regulatory and labeling complexities raise barriers for smaller entrants and contribute to uneven product consistency across markets.
Other drivers and restraints analyzed in the detailed report include:
- Preventive Veterinary Care and Owner Nutrition Awareness
- Evidence-Based Nutraceuticals, Probiotics, and Clean-Label Innovation
- Premium Pricing Constrains Adoption in Price-Sensitive Cohorts
Segment Analysis
Joint & Bone Health accounted for the largest slice of the equine supplement products market in 2025 at 34.56%, reflecting the ongoing need to maintain soundness in both performance and aging horses. The equine supplements industry is adding multi-modal support inputs that complement traditional glucosamine-chondroitin and hyaluronic acid matrices with targeted anti-inflammatory and connective tissue support.Natural eggshell membrane has moved into the discussion after a February 2026 clinical study in Warmblood horses showed functional improvements over a 12-week schedule, which has helped expand formulator interest in collagen-rich complexes. Separate evidence in companion animals where curcumin C3 Complex combined with glucosamine and chondroitin reduced osteoarthritis severity has supported cross-species ingredient screening for equine joint health. Sports integrity is a parallel focus, and brands that operate in Europe emphasize quality systems and third-party testing frameworks to meet clean-sport expectations around competition eligibility. These trends are creating a more evidence-aware buyer who weighs ingredient provenance and trial endpoints when selecting joint formulas.
Hoof & Laminitis Support is the fastest-growing sub-application with a 4.51% CAGR forecast, and its momentum reflects closer coordination between farriers, veterinarians, and nutritionists targeting preventive lameness. Research into methylated tirilazad has reported reductions in laminar matrix metalloproteinase activity in experimental models, and although not yet approved for equine use, this work informs anti-inflammatory strategies that developers are tracking for future formulations. Biotin remains a staple of hoof support, and company guidance around sustained dosing supports owner compliance and farrier recommendations over extended time frames.
Digestive and gut health applications have expanded due to rising microbiome awareness, with attention to prebiotics that may support mucosal health in horses vulnerable to colic. As early evidence grows, application-level portfolios are tilting toward precision approaches rather than broad-spectrum blends, which can translate into clearer use cases at the point of care. These shifts reinforce the premium tier while also pushing formulators to document outcomes for owner-facing education and veterinary collaboration.
Proteins & Amino Acids led ingredient demand with a 41.24% share in 2025, supported by lysine, methionine, and threonine to aid topline development, hoof keratin quality, and reproductive function. The equine supplement products market continues to incorporate these building blocks in balanced rations, often anchored by essential amino acid combinations within broader feed and supplement regimens. Botanical and nutraceutical inputs are the fastest-growing at a 4.14% CAGR, supported in the United States by regulatory clarity that AAFCO-listed feed ingredients can move across state lines, which reduces uncertainty for compliant ingredient use in commercial products.
Clean-label strategies are gaining prominence, including the use of wild-harvested or minimally processed actives and transparent supply chains, as shown by company announcements that emphasize natural sourcing and formula simplicity. This momentum increases the need for validated dosing protocols and supporting data so owners and clinicians can line up ingredients with intended outcomes across metabolic and performance profiles. As ingredient portfolios broaden, product developers are also addressing carrier systems and stability to protect bioactive integrity through the digestive tract.
Vitamins present a mixed picture due to organic compliance challenges that stem from widespread use of genetically modified microorganisms in industrial production of certain B vitamins. The 2024 USDA National Organic Program report highlighted riboflavin and other vitamins as typically produced through GMO fermentation, which complicates organic claims for equine feeds and supplements without transparent disclosures or alternative sourcing.
Enzymes, probiotics, and synbiotics remain active areas for development, though studies in healthy horses show that not all commercial probiotic blends produce measurable immunological or microbiota shifts, encouraging more targeted strain selection and context-specific use. Electrolytes and minerals, including chelated forms of copper, zinc, and manganese, continue to be staples due to their roles in thermoregulation and musculoskeletal function in training and competition settings. With a growing body of microbiome and nutraceutical evidence, brands are adopting tighter documentation practices for both raw material credentials and finished-product testing. This combination of scientific discipline and quality control underpins the premiumization visible across leading ingredient segments.
Complete Report Scope:
- By Health Benefit / Application
- Joint & Bone Health
- Digestive / Gut Health
- Hoof & Laminitis Support
- Vitamins & Minerals (General Health & Immunity)
- Skin & Coat
- Calming & Nervous System
- Respiratory & Immune Support
- Performance & Energy / Recovery
- Senior / Metabolic Support
- By Ingredient Type
- Proteins & Amino Acids
- Vitamins
- Enzymes / Probiotics / Synbiotics
- Electrolytes & Minerals
- Herbal / Botanical / Nutraceutical
- By Form
- Powders
- Liquids
- Pellets & Granules
- Pastes & Gels
- Chewables / Treats
- By Distribution Channel
- Veterinary Hospitals & Clinics
- Pharmacies & Drug Stores
- Equine Specialty & Tack Stores
- Feed & Farm Supply Stores
- Online Retail (Marketplaces & D2C)
- Supermarkets & Hypermarkets
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America led the equine supplement products market with a 42.67% share in 2025, reflecting a deep base of competition disciplines, breeding programs, and sport-adjacent infrastructure that supports specialized nutrition demand. Regulatory clarification on AAFCO-defined ingredients has improved predictability for interstate commerce and online fulfillment, which aligns with the region’s strong adoption of D2C and marketplace channels. In Canada, suppliers with equine-specialist manufacturing and integrated education services contribute to regional growth by pairing science-based content with practitioner support.Within the United States, labeling guidance for new animal drugs reinforces the need for clear label claims and careful separation between feed and drug positioning for any product that edges into therapeutic territory. With a large installed base of performance horses and a well-developed veterinary ecosystem, North America remains central to early adoption of innovation and to scaling clinically guided product lines. Overall, the region’s regulation, channel maturity, and customer education form a stable foundation for premiumization.
Europe displays steady growth under stricter pharmacovigilance and feed hygiene oversight, which encourages investments in quality systems and clean-sport validation. Brands that operate in the United Kingdom have retooled distribution relationships following post-Brexit trade changes, and a notable 2026 partnership for exclusive distribution has strengthened channel alignment for a leading sport-nutrition brand.
Asia-Pacific is projected to be the fastest-growing region with a 5.01% CAGR, a reflection of expanding equestrian participation and entrenched racing cultures that prioritize performance nutrition. Product development in Japan tends to emphasize microencapsulation and fermentation-derived inputs in line with local preferences for biotech-enabled nutrition, while Australia’s regulatory environment facilitates timely market access for compliant formulations. The equine supplement products market size in this region is influenced by a rising base of urban and peri-urban riders in select countries and by coaching ecosystems that encourage structured nutrition management across disciplines.
List of Companies Covered in this Report:
- Alltech (LIFEFORCE)
- Blue Chip Feed
- Buckeye Nutrition
- Cavalor
- Equine Products UK Ltd
- Foran Equine
- Grand Meadows
- Hilton Herbs
- Kentucky Performance Products (KPP)
- Life Data Labs (Farrier’s Formula)
- Mad Barn
- NAF (Natural Animal Feeds)
- Nettex Equine
- Nutrena (Empower)
- Plusvital
- TRM (Thoroughbred Remedies Manufacturing)
- Uckele Health & Nutrition
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts (Value, USD)
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alltech (LIFEFORCE)
- Blue Chip Feed
- Buckeye Nutrition
- Cavalor
- Equine Products UK Ltd
- Foran Equine
- Grand Meadows
- Hilton Herbs
- Kentucky Performance Products (KPP)
- Life Data Labs (Farrier’s Formula)
- Mad Barn
- NAF (Natural Animal Feeds)
- Nettex Equine
- Nutrena (Empower)
- Plusvital
- TRM (Thoroughbred Remedies Manufacturing)
- Uckele Health & Nutrition
